Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 1, 1998, Pages 54-59

  Streicher, Johannes ^a,c   Fabian, Barbara ^b   Herkner, Kurt ^a   Pointner, Herwig ^b   Bayer, Peter M ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c Department of Pediatrics University of Vienna ^*  (Austria)

Author keywords

Anticytokeratin antibodies; NCA; NCA detection; Streptococcal sepsis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; CYTOKERATIN; CYTOKERATIN ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PROTEIN INDUCTION; SEPSIS; STREPTOCOCCUS INFECTION; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

STREPTOCOCCUS;

EID: 0031913576     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:1<54::AID-JCLA9>3.0.CO;2-J     Document Type: Article

References (47)

1. Davis DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? Br Med J 285:606, 1982.
2. Van der Woude FJ, Rasmussen N, Lobatto S, et al.: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-429, 1985.
3. Falk RJ, Jenette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657, 1988.
4. Gross WL, Hauschild S, Mistry N: The clinical relevance of ANCA in vasculitis. Clin Exp Immunol 93(Supplement 1): 7-11, 1993.
5. Kallenberg CGM, Brouwer E, Weening JJ, Tervaert JW: Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 46:1-15, 1994.
6. Goldschmeding R, van der School CE, ten Bokkel Huinink D, et al: Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorphosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577-1587, 1989.
7. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888-1893, 1989.
8. Lüdemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362, 1990.
9. Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL: Wegener's autoantigen decoded. Nature 346:520, 1990.
10. Jennette JC, Hoidal JR, Falk RJ: Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75:2263-2264, 1990.
11. Mårtensson U, Nässberger L: Circulating antibodies directed against β-glucuronidase. Autoimmunity 11:213-214, 1992.
12. Coremans IEM, Hagen EC, van der Woude FJ, et al: Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 35:1466-1475, 1992.
13. Zhao MH, Jones SJ, Lockwood CM: Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in vasculitis. Clin Exp Immunol 99:49-56, 1995.
14. Stoffel MP, Csernok E, Herzberg C, Johnston T, Carroll SF, Gross WL: Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): A new seromarker for inflammatory bowel disease and associate disorders. Clin Exp Immunol 104:54-59, 1996.
15. Jennette JC, Falk RJ: Diagnostic classification of antineutrophil cytoplasmic antibody-associated vasculitides. Am J Kidney Dis 18:184-187, 1991.
16. Gross WL, Hauschild S, Schmitt WH: Immundiagnostische und immunpathogenetische Bedeutung von Anti-Neutrophilen-Cytoplasma-Antikörpern. Dtsch Med Wochenschr 118:191-199, 1993.
17. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of vasculitides: The proposal of an international consensus conference. Arthritis Rheum 37:187-192, 1994.
18. Braun MG, Csernok E, Schmitt WH, Gross WL: Incidence and specificity of p-ANCA in rheumatic diseases. In: Advances in Experimental Medicine and Biology, Abstract Book of the Fourth International Workshop on ANCA. Gross WL, ed. London: Plenum, 1992, p 48.
19. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allerg Clin Immunol 86:202-210, 1990.
20. Mulder AHL, Horst G, Broekroelofs G: ANCA in inflammatory bowel disease recognize several antigens. In: Advances in Experimental Medicine and Biology, Abstract Book of the Fourth International Workshop on ANCA. Gross WL, ed. London: Plenum, 1992, p 8.
21. Hagen EC, for the EEC/BCR Group for ANCA Assay Standardization: Development for new solid phase assays for the detection of anti-proteinase-3 antibodies. In: Advances in Experimental Medicine and Biology, Abstract Book of the Fourth International Workshop on ANCA Gross WL, ed. London: Plenum, 1992, p 8.
22. Jennings JG, Chang L, Savige JA: Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 95:251-256, 1994.
23. Hagen EC, Andrassy K, Csernok E, et al: The value of indirect immunofluorescence and solid phase techniques for ANCA detection: A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 159:1-16, 1993.
24. Specks U, Homburger HA: Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc 69:1197-1198, 1994
25. Schmitt WH, Gross WL: Antineutrophile zytoplasmatische Antikörper (ANCA). Internist 36:282-290, 1995.
26. st international workshop on ANCA, 1988. APMIS 97 (Suppl 6): 16-20, 1989.
27. Stroncek DF, Egging MS, Eiber GA, Clay ME: Neutrophil alloantibodies react with cytoplasmic antigens: A possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. Am J Kidney Dis 21:368-373, 1993.
28. Pudifin DJ, Duursma J, Gathiram J, Jackson TFHG: Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol 97:48-51, 1994.
29. Dolman KM, Gans RO, Vervaat TJ, et al: Vasculitic disorders and antineutrophil cytoplasmic antibodies associated with propylthiouracil therapy. Lancet 342:651-652, 1993.
30. Klaassen RJ, Goldschmeding R, Dolman KM, et al: Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 87:24-30, 1992.
31. Davenport A: "False-positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 37:124-130, 1992.
32. Members of the ACCP/SCCM consensus conference committee: American college of chest physicians/society of critical care medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
33. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 97 (Suppl 6): 12-13, 1989.
34. Franke WW, Kartenbeck J: Cytokeratins In: Cytoskeletal and Motor Proteins T Kreis, R Vale, eds. Oxford Univ. Press, New York, 1993, p 145-148.
35. Markl J: Cytokeratins in mesenchymal cells: Impact on functional concepts of the diversity of intermediate filament proteins. J Cell Science 98:261-264, 1991.
36. Segelmark M, Baslund B, Wielander J: Some Patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern. Clin Exp Immunol 96:458-465, 1994.
37. Wachter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Buschenfelde KH, Manns M: Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol 11:232-239, 1990.
38. Kobayashi T, Nakanishi K, Kajio H, et al: Pancreatic cytokeratin: An antigen of pancreatic exocrine cell autoantibodies in type I (insulin-dependent) diabetes mellitus. Diabetologia 32:263-270, 1990.
39. Borg AA, Nixon NB, Dawes PT, Mattey DL: Increased IgA antibodies to cytokeratins in the spondyloarthropathies. Ann Rheum Dis 53:391-395, 1994.
40. Mayet WJ, Press AG, Hermann E, et al: Antibodies to cytoskeletal proteins in patients with Crohn's disease Eur J Clin Invest 20:516-524, 1990.
41. Karlsson-Parra A, Burman P, Hagberg H, et al: Autoantibodies to epithelial cells in patients on long-term therapy with leukocyte-derived interferon-alpha (IFN-alpha). Clin Exp Immunol 81:72-75, 1990.
42. Mayet WJ, Wandel E, Hermann E, Dumann H, Kohler H: Antibodies to cytoskeletal components in patients undergoing long-term hemodialysis detected by a sensitive enzyme-linked immunosorbent assay (ELISA). Clin Nephrol 33:272-278, 1990.
43. Mege JL, Escallier JC, Capo C, et al: Anti-neutrophil cytoplasmic autoantibodies (ANCA) and infection. Adv Exp Med Biol 336:353-356, 1993.
44. Milesi-Lecat AM, Aumaitre O, Deusebis T, et al: Semi-invasive diffuse pulmonary aspergillosis with antineutrophil cytoplasmic antibodies. 2 cases. Ann Med Interne Paris 145:140-146, 1994.
45. Mezzao S, Valderrama G, Olavarria F, et al: Antineutrophil-cytoplasmic-autoantibodies in poststreptococcal nephritis. Adv Exp Med Biol 336:449-453, 1993.
46. Shoenfeld Y: Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 8:1296-1301, 1994.
47. Baboonian C, Venables PJW, Williams DG, Williams RO, Maini RN: Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis 50:772-775, 1991.